Article

CYP2C19*2 genetic polymorphism and incidence of in-stent restenosis in patients on clopidogrel: A matched case-control study

2021-04-27

Abstract excerpt

<title>Abstract</title> <p>Background: The cytochrome P450 2C19 *2 ( CYP2C19*2 ) genetic polymorphism is associated with reduced clopidogrel bioactivation, increasing the risk of atherothrombotic complications after percutaneous coronary intervention (PCI). In-stent restenosis (ISR) is a complication that limits the long-term prognosis of PCI. <h4>Objective:</h4> To investigate the association between CYP2C19*2 a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9e86e382-b441-5bd1-83d5-20b984375a24
DOI: 10.21203/rs.3.rs-456499/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CYP2C19*2 genetic polymorphism and incidence of in-stent restenosis in patients on clopidogrel: A matched case-control studyDOI 10.21203/rs.3.rs-456499/v1Read

CYP2C19*2 genetic polymorphism and incidence of in-stent restenosis in patients on clopidogrel: a matched case-control study.Semantic proximity Read

CYP2C19⁎2 Polymorphism in Chilean Patients with In-Stent Restenosis Development and Controls.Semantic proximity Read

Clinical Outcomes after Percutaneous Coronary Intervention Over Time on the Basis of CYP2C19 Polymorphisms: Evidence from a Chinese CohortSemantic proximity Read

CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study.Semantic proximity Read

Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects.Semantic proximity Read

Cytochrome P450 CYP 2C19*2 Associated with Adverse 1-Year Cardiovascular Events in Patients with Acute Coronary Syndrome.Semantic proximity Read

Cytochrome P-450 CYP2C19 genetic polymorphism and its relation with clopidogrel resistance.Semantic proximity Read

Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel.Semantic proximity Read

Association between cytochrome P450 2C19 polymorphism and clinical outcomes in clopidogrel-treated Uygur population with acute coronary syndrome: a retrospective study.Semantic proximity Read

Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.Semantic proximity Read

Cytochrome P450 2C19 polymorphism and antiplatelet therapy. Who should really be genotyped?Semantic proximity Read

Association of cytochrome P450 2C19*2 polymorphism with clopidogrel response variability and cardiovascular events in Koreans treated with drug-eluting stents.Semantic proximity Read